A detailed history of Epoch Investment Partners, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 226,655 shares of UTHR stock, worth $79.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
226,655
Previous 213,498 6.16%
Holding current value
$79.9 Million
Previous $49 Million 47.21%
% of portfolio
0.34%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $3 Million - $4.2 Million
13,157 Added 6.16%
226,655 $72.2 Million
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $67,232 - $79,593
319 Added 0.15%
213,498 $49 Million
Q4 2023

Feb 13, 2024

BUY
$214.88 - $256.94 $16.2 Million - $19.4 Million
75,400 Added 54.73%
213,179 $46.9 Million
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $1.48 Million - $1.73 Million
-6,986 Reduced 4.83%
137,779 $31.1 Million
Q2 2023

Aug 11, 2023

SELL
$205.19 - $232.99 $925,817 - $1.05 Million
-4,512 Reduced 3.02%
144,765 $32 Million
Q1 2023

May 12, 2023

SELL
$212.99 - $276.17 $10.5 Million - $13.7 Million
-49,521 Reduced 24.91%
149,277 $33.4 Million
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $14.7 Million - $20 Million
-71,344 Reduced 26.41%
198,798 $55.3 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $5.34 Million - $6.41 Million
-26,243 Reduced 8.85%
270,142 $56.6 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $10.6 Million - $14.6 Million
-60,554 Reduced 16.96%
296,385 $69.8 Million
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $4.59 Million - $5.92 Million
27,652 Added 8.4%
356,939 $64 Million
Q4 2021

Feb 11, 2022

BUY
$184.32 - $216.08 $13.6 Million - $16 Million
73,816 Added 28.89%
329,287 $71.2 Million
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $45.9 Million - $54.9 Million
255,471 New
255,471 $47.2 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.